Pharmacovigilance & Medical Device Adverse Event Monitoring Centre
Adverse Drug Reaction Monitoring Centre (AMC)
SVIMS, Tirupati is recognized as an Adverse Drug Reaction Monitoring Centre (AMC) and approved by the Indian Pharmacopoeia Commission - National Coordinating Centre (PvPI), Ghaziabad on 08/07/2015. We play a crucial role in safeguarding patient health by systematically monitoring, assessing, and responding to adverse drug reactions (ADRs).
Objectives:
- Monitor and document adverse drug reactions (ADRs) in inpatient and outpatient settings.
- Promote awareness and education on drug safety among healthcare professionals.
- Encourage timely and accurate reporting of ADRs by clinicians, nursing staff, and pharmacists.
- Analyze data to identify trends, evaluate risk factors, and recommend interventions.
- Collaborate with the Pharmacovigilance Programme of India (PvPI) and other regulatory bodies.
- Conduct regular training, workshops, and continuing medical education (CME) programs on pharmacovigilance.
Key Activities:
- Collection, analysis, and causality assessment of ADR reports from all clinical departments.
- Conducting monthly Pharmacovigilance Committee meetings to review and discuss the ADRs collected throughout the month.
- Monthly meetings are held to perform causality assessment of the ADRs by committee experts.
- Organizing awareness programs and pharmacovigilance workshops for medical and nursing staff.
- Publishing safety bulletins and updates regarding drug reactions and recalls.
- Promoting student and intern participation in pharmacovigilance practices.
- Ensuring confidentiality, integrity, and proper documentation of pharmacovigilance data.
Committee Members (PVC)
| S. No |
Name of the Faculty |
Designation |
PVC Role |
| 01 | Dr. Usha Kalawat | Principal | Chairman |
| 02 | Dr. R. Ram | Professor & HOD of Nephrology | Co-Chairman |
| 03 | Dr. K. Umamaheswara Rao | Professor & HOD of Pharmacology | Co-ordinator |
| 04 | Dr. C. Pallavi | Associate Professor of Pharmacology | Deputy Co-ordinator |
| 05 | Dr. K. ChandraSekhar | Assistant Professor of Medicine | Member |
| 06 | Dr. Y. Mutheeswaraiah | Professor & HOD of General Surgery | Member |
| 07 | Dr. K. Vijaya Chandra Reddy | Professor of Pharmacology | Member |
| 08 | Dr. Punith Patak | Professor & HOD of Paediatrics | Member |
| 09 | Dr. A. Surekha | Associate Professor & I/C HOD, Dermatology | Member |
| 10 | Mrs. Prabhavathi | D.D. Nursing | Member |
Junior Pharmacovigilance Associate: Mrs. M.K. Manisha, M. Pharm, appointed by the Indian Pharmacopoeia Commission- NCC (PvPI), Ghaziabad.
Medical Device Adverse Event Monitoring Centre
Officially designated as a Medical Device Adverse Event (MDAE) Monitoring Centre with effect from August 23, 2022. This initiative enhances patient safety by systematically monitoring events related to medical devices.
- Chairperson: Dr. Ram (Medical Superintendent)
- Coordinator: Ms. G. Pavani (Biomedical Technician)
Our Commitment: At SVIMS, pharmacovigilance is a critical element of clinical care. We aim to minimize drug-related harm and continuously improve the standards of patient safety and public health.